World Pharma News Digest - 29.05.2012
0 views
Skip to first unread message
Ruslan David
May 29, 2012, 7:58:03 AM5/29/12
to worldph...@googlegroups.com
Lundbeck's Lu AE58054 meets primary endpoint
H. Lundbeck A/S (Lundbeck) today announced that Lu AE58054 has met its primary endpoint in a fixed dose, randomized, placebo-controlled clinical study in 278 patients suffering from Alzheimer's disease.
Read more...
http://www.worldpharmanews.com/lundbeck/2092-lundbecks-lu-ae58054-meets-primary-endpoint
H. Lundbeck A/S (Lundbeck) today announced that Lu AE58054 has met its primary endpoint in a fixed dose, randomized, placebo-controlled clinical study in 278 patients suffering from Alzheimer's disease.
Read more...
http://www.worldpharmanews.com/lundbeck/2092-lundbecks-lu-ae58054-meets-primary-endpoint
Thioridazine, successfully kills cancer stem cells in the human
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.
Read more...
http://www.worldpharmanews.com/research/2091-thioridazine-successfully-kills-cancer-stem-cells-in-the-human
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.
Read more...
http://www.worldpharmanews.com/research/2091-thioridazine-successfully-kills-cancer-stem-cells-in-the-human
World Health Assembly endorses new plan to increase global access to vaccines
Ministers of Health from 194 countries at the Sixty-fifth World Health Assembly endorsed a landmark Global Vaccine Action Plan (GVAP), a roadmap to prevent millions of deaths by 2020 through more equitable access to existing vaccines for people in all communities.
Read more...
http://www.worldpharmanews.com/development/2090-world-health-assembly-endorses-new-plan-to-increase-global-access-to-vaccines
Ministers of Health from 194 countries at the Sixty-fifth World Health Assembly endorsed a landmark Global Vaccine Action Plan (GVAP), a roadmap to prevent millions of deaths by 2020 through more equitable access to existing vaccines for people in all communities.
Read more...
http://www.worldpharmanews.com/development/2090-world-health-assembly-endorses-new-plan-to-increase-global-access-to-vaccines
Innovative public-private collaboration launches to tackle antibiotic research
GlaxoSmithKline and AstraZeneca welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat from antibiotic resistance and address some of the key barriers to the development of effective antibiotics.
Read more...
http://www.worldpharmanews.com/gsk/2089-innovative-public-private-collaboration-launches-to-tackle-antibiotic-research
GlaxoSmithKline and AstraZeneca welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat from antibiotic resistance and address some of the key barriers to the development of effective antibiotics.
Read more...
http://www.worldpharmanews.com/gsk/2089-innovative-public-private-collaboration-launches-to-tackle-antibiotic-research
Calcium supplements linked to significantly increased heart attack risk
Calcium supplements might increase the risk of having a heart attack, and should be "taken with caution," concludes research published in the online issue of the journal Heart. Furthermore, boosting overall calcium intake from dietary sources confers no significant advantage in terms of staving off heart disease and stroke, the findings indicate.
Read more...
http://www.worldpharmanews.com/research/2088-calcium-supplements-linked-to-significantly-increased-heart-attack-risk
Calcium supplements might increase the risk of having a heart attack, and should be "taken with caution," concludes research published in the online issue of the journal Heart. Furthermore, boosting overall calcium intake from dietary sources confers no significant advantage in terms of staving off heart disease and stroke, the findings indicate.
Read more...
http://www.worldpharmanews.com/research/2088-calcium-supplements-linked-to-significantly-increased-heart-attack-risk
Bayer's Regorafenib submitted for EU and US marketing authorization
Bayer HealthCare has submitted a Marketing Authorization Application to the European Medicines Agency (EMA) and a New Drug Application to the U.S. Food and Drug Administration (FDA) for the oral multi-kinase inhibitor regorafenib for the treatment of patients with metastatic colorectal cancer (mCRC).
Read more...
http://www.worldpharmanews.com/bayer/2087-bayers-regorafenib-submitted-for-eu-and-us-marketing-authorization
Bayer HealthCare has submitted a Marketing Authorization Application to the European Medicines Agency (EMA) and a New Drug Application to the U.S. Food and Drug Administration (FDA) for the oral multi-kinase inhibitor regorafenib for the treatment of patients with metastatic colorectal cancer (mCRC).
Read more...
http://www.worldpharmanews.com/bayer/2087-bayers-regorafenib-submitted-for-eu-and-us-marketing-authorization
One million signatures needed to call upon World Health Organisation
The 1 Mission 1 Million - Getting to the Heart of Stroke initiative is launching a petition to call upon the World Health Organisation, its member states and health authorities worldwide to recognise atrial fibrillation as a risk factor for stroke and set clinical management targets that could save one million mothers, fathers, uncles, aunts and grandparents each year through better atrial fibrillation management, stroke prevention and education.
Read more...
http://www.worldpharmanews.com/boehringer-ingelheim/2086-one-million-signatures-needed-to-call-upon-world-health-organisation
The 1 Mission 1 Million - Getting to the Heart of Stroke initiative is launching a petition to call upon the World Health Organisation, its member states and health authorities worldwide to recognise atrial fibrillation as a risk factor for stroke and set clinical management targets that could save one million mothers, fathers, uncles, aunts and grandparents each year through better atrial fibrillation management, stroke prevention and education.
Read more...
http://www.worldpharmanews.com/boehringer-ingelheim/2086-one-million-signatures-needed-to-call-upon-world-health-organisation
Biomarker predicts response to cancer treatment
VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab (Avastin). If validated, this discovery could be an important step towards personalized medicine and patient-tailored use of this important cancer drug.
Read more...
http://www.worldpharmanews.com/research/2085-biomarker-predicts-response-to-cancer-treatment
VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab (Avastin). If validated, this discovery could be an important step towards personalized medicine and patient-tailored use of this important cancer drug.
Read more...
http://www.worldpharmanews.com/research/2085-biomarker-predicts-response-to-cancer-treatment
FDA approves generic versions of blood thinner Plavix
The U.S. Food and Drug Administration approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Read more...
http://www.worldpharmanews.com/fda/2084-fda-approves-generic-versions-of-blood-thinner-plavix
The U.S. Food and Drug Administration approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Read more...
http://www.worldpharmanews.com/fda/2084-fda-approves-generic-versions-of-blood-thinner-plavix
PharmaNews.eu / Latest News
Novo Nordisk receives positive opinion on recombinant factor XIII
http://www.pharmanews.eu/novo-nordisk/1063-novo-nordisk-receives-positive-opinion-on-recombinant-factor-xiii
http://www.pharmanews.eu/novo-nordisk/1063-novo-nordisk-receives-positive-opinion-on-recombinant-factor-xiii
Innovative public-private collaboration launches to tackle antibiotic research
http://www.pharmanews.eu/astrazeneca/1062-innovative-public-private-collaboration-launches-to-tackle-antibiotic-research
http://www.pharmanews.eu/astrazeneca/1062-innovative-public-private-collaboration-launches-to-tackle-antibiotic-research
IMI launches €223.7 million programme for combatting antibiotic resistance
http://www.pharmanews.eu/research-and-development/1061-imi-launches-2237-million-programme-for-combatting-antibiotic-resistance
http://www.pharmanews.eu/research-and-development/1061-imi-launches-2237-million-programme-for-combatting-antibiotic-resistance
One million signatures needed to call upon World Health Organisation
http://www.pharmanews.eu/boehringer-ingelheim/1060-one-million-signatures-needed-to-call-upon-world-health-organisation
http://www.pharmanews.eu/boehringer-ingelheim/1060-one-million-signatures-needed-to-call-upon-world-health-organisation
Biomarker predicts response to cancer treatment
http://www.pharmanews.eu/research-and-development/1059-biomarker-predicts-response-to-cancer-treatment
http://www.pharmanews.eu/research-and-development/1059-biomarker-predicts-response-to-cancer-treatment
Heparin-like compounds inhibit breast cancer metastasis to bone
http://www.pharmanews.eu/research-and-development/1058-heparin-like-compounds-inhibit-breast-cancer-metastasis-to-bone
http://www.pharmanews.eu/research-and-development/1058-heparin-like-compounds-inhibit-breast-cancer-metastasis-to-bone
Health 2.0 Europe 2012 - Over 20 speakers already confirmed
http://www.pharmanews.eu/conferences-and-events/1057-health-20-europe-2012-over-20-speakers-already-confirmed
http://www.pharmanews.eu/conferences-and-events/1057-health-20-europe-2012-over-20-speakers-already-confirmed
With best regards,
Ruslan David
Administrator/Editor
Ruslan David
Administrator/Editor
PS: Want to place your News, Brand, Service, Product or Event in front of World Pharma News?
World Pharma News' strong, innovative capabilities can ensure you to create a compelling advertising campaign that reaches all your objectives and desired audiences. For further information, please download World Pharma News' Media Pack (.pdf, 319 KB).
http://www.worldpharmanews.com/contact-us
World Pharma News' strong, innovative capabilities can ensure you to create a compelling advertising campaign that reaches all your objectives and desired audiences. For further information, please download World Pharma News' Media Pack (.pdf, 319 KB).
http://www.worldpharmanews.com/contact-us
Reply all
Reply to author
Forward
0 new messages